Dynamics in statin use, low density lipoprotein cholesterol levels and Parkinson’s disease. A population-based cohort study using big-data
Objective: To evaluate the association between time-varying statin use and PD risk in a large-scale population-based study. Background: Statins have been shown to downregulate neuroinflammation,…Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease
Objective: To evaluate prevalence of nanometer symptoms in patients with Parkinson's disease. Background: While PD (Parkinson's disease) is diagnosed on the basis of motor symptoms,…Cardiovascular and cerebrovascular disorders are associated with a higher prevalence of parkinsonism: Data from a neuroepidemiologic community-based survey
Objective: To evaluate the association between comorbidity profile (consisting of the cardiovascular and cerebrovascular diseases) and the prevalence of parkinsonism using data from a neuroepidemiologic…Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study
Objective: To determine the prevalence of Parkinson's disease (PD) and Myotonic Dystrophy (MD) in the isolated people, where a study never been conducted before regarding…Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry
Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…Dementia in adult type 2 diabetes patients – An analysis from the multicenter German/Austrian diabetes patient follow-up registry DPV
Objective: To study the presence of dementia in older people with Type 2 diabetes mellitus (T2DM) and to compare demographics with non-demented T2DM patients. Background:…Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1
Objective: To report the statistical analyses exploring the association between BMI and change in Unified Parkinson's disease Rating Scale (UPDRS) scores and survival in the…Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?
Objective: To analyze the association between aminosalicylate-treated inflammatory bowel disease (IBD-A) and Parkinson´s disease (PD) at population level. Background: According to the dual-hit hypothesis, the…Prevalence of Parkinson’s disease in Ukraine
Objective: To compare the prevalence of Parkinson's disease (PD) in Ukraine in 2010 and 2014; to compare the prevalence of PD in Ukraine with other…Underutilization of physiotherapy for Parkinson’s disease in the United States
Objective: To examine allied health care (AHC) utilization in older adults with Parkinson's disease in the United States. Background: Multiple studies have demonstrated the efficacy…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.